Wf. Riker et al., IN-VIVO REVERSAL OF DEPOLARIZING NEUROMUSCULAR BLOCKADE, Archives internationales de pharmacodynamie et de therapie, 330(1), 1995, pp. 90-101
The antagonism of depolarizing blockers. principally succinylcholine a
nd decamethonium, by tetraethyl- and tetrabutylammonium ions in an in
vivo neuromuscular preparation in anesthetized cats is described; poss
ible mechanisms for these effects are discussed. Tetraethyl- (50-100 m
g/kg, i.v.) and tetrabutylammonium (1-5 mg/kg, i.v.) produced sharp re
versals of 95-99% succinylcholine and decamethonium blocks. These reve
rsals were effective and sustained at any point during the course of t
he blockades. Tetraethyl- or tetrabutylammonium, administered 2-3 min
before succinylcholine or decamethonium, prevented blockade, an effect
compatible with an earlier reported in vitro investigation. The studi
es of others disclose the interaction of depolarizing blockers with ac
etylcholine receptors. leading to channel opening: channel entry and b
inding therein of these blockers. The present studies support this in
showing the prevention of succinylcholine and decamethonium block by t
he prior administration of tetraethylammonium, which also interacts wi
th acetylcholine receptors. It is proposed that a possible mechanism f
or tetraethylammonium reversals of succinylcholine and decamethonium b
locks may be attributable to the tetraethylammonium reversal of a K+ c
urrent block by quaternary ammonium ions such as succinylcholine and d
ecamethonium. Tetraethyl- and tetrabutylammonium ions proved to be eff
ective antagonists of succinylcholine block following inactivation of
plasma cholinesterases by hexafluorenium.